Logo
x

Search

Subscribe Now

Treating

Signifier's eXciteOSA Receives US FDA's Approval for the Treatment of Mild Obstructive Sleep Apnea and Snoring

Signifier's eXciteOSA Receives US FDA's Approval for the Treatment of Mild Obstructive Sleep Apnea and Snoring

  • February 9, 2021
STADA Expands its Specialty Footprint with the Acquisition of Lobsor Pharmaceuticals

STADA Expands its Specialty Footprint with the Acquisition of Lobsor Pharmaceuticals

  • October 5, 2020
GSK to Evaluate Otilimab for Treating Pulmonary Disease Associated with COVID-19

GSK to Evaluate Otilimab for Treating Pulmonary Disease Associated with COVID-19

  • May 8, 2020
I-Mab to Initiate the Development of TJM2 for Treating Cytokine Release Syndrome Associated with COVID-19

I-Mab to Initiate the Development of TJM2 for Treating Cytokine Release Syndrome Associated with COVID-19

  • March 13, 2020
IMIDomics Collaborates with Gossamer Bio to Develop Therapies for Treating Immune-Mediated Inflammatory Diseases

IMIDomics Collaborates with Gossamer Bio to Develop Therapies for Treating Immune-Mediated Inflammatory Diseases

  • February 4, 2020
BeiGene Signs an Exclusive Worldwide License Agreement with Seattle Genetics to Advance Preclinical Candidates Treating Cancer

BeiGene Signs an Exclusive Worldwide License Agreement with Seattle Genetics to Advance Preclinical Candidates Treating Cancer

  • November 6, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.